As of 12:44:45 PM EST. Market Open.
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
1,488,094.0000
1,540,907.0000
1,318,569.0000
1,005,536.0000
Total Liabilities Net Minority Interest
335,776.0000
307,630.0000
292,836.0000
175,028.0000
Total Equity Gross Minority Interest
1,152,318.0000
1,233,277.0000
1,025,733.0000
830,508.0000
Total Capitalization
1,152,318.0000
1,233,277.0000
1,025,733.0000
830,508.0000
Common Stock Equity
1,152,318.0000
1,233,277.0000
1,025,733.0000
830,508.0000
Capital Lease Obligations
77,380.0000
82,258.0000
40,065.0000
4,390.0000
Net Tangible Assets
984,087.0000
1,053,969.0000
829,535.0000
683,855.0000
Working Capital
752,972.0000
907,171.0000
809,124.0000
709,835.0000
Invested Capital
1,152,318.0000
1,233,277.0000
1,025,733.0000
830,508.0000
Tangible Book Value
984,087.0000
1,053,969.0000
829,535.0000
683,855.0000
Total Debt
77,380.0000
82,258.0000
40,065.0000
4,390.0000
Share Issued
290,824.9700
286,851.5950
283,257.1040
269,497.7680
Ordinary Shares Number
290,824.9700
286,851.5950
283,257.1040
269,497.7680
12/31/2020 - 12/11/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ABSI Absci Corporation
2.9200
-2.34%
BEAM Beam Therapeutics Inc.
29.16
+0.52%
NTLA Intellia Therapeutics, Inc.
12.09
-0.74%
DNA Ginkgo Bioworks Holdings, Inc.
9.32
-7.54%
CRBU Caribou Biosciences, Inc.
1.7852
-0.82%
EDIT Editas Medicine, Inc.
1.2800
-2.29%
FATE Fate Therapeutics, Inc.
1.6700
-0.60%
ADPT Adaptive Biotechnologies Corporation
6.37
-0.31%
RXRX Recursion Pharmaceuticals, Inc.
6.67
+10.53%
VERV Verve Therapeutics, Inc.
5.91
+2.96%